X-ray irradiation promotes apoptosis of hippocampal neurons through up-regulation of Cdk5 and p25
- Ai-Min Sun†1,
- Chuan-Gang Li†2,
- Yong-Qing Han1, 4,
- Que-Ling Liu1, 5,
- Qiong Xia3 and
- Ya-Wei Yuan1Email author
© Sun et al.; licensee BioMed Central Ltd. 2013
Received: 3 February 2013
Accepted: 14 April 2013
Published: 20 May 2013
Cranial radiation therapy has been used for the treatment of primary and metastatic brain tumors. A prominent feature of brain injury induced by the radiation therapy is hippocampal dysfunction, characterized by a decline in memory. Cdk5 plays an important role in memory formation. Abnormal Cdk5 activity is associated with neuronal apoptosis induced by neurotoxic stimuli. However, the roles of Cdk5 in hippocampal apoptosis in response to X-ray irradiation have not been explored.
The expression of Cdk5 activators, p35 and p25, in hippocampal neurons was tested in both in vivo animal and in vitro couture after X-ray irradiation.
After X-ray irradiation at 20 Gy and 30 Gy in rats, the number of hippocampal neuronal pyknosis was increased, but the number of hippocampal neuron was decreased, in the hippocampal CA1 region of rats. In these animals undergone with X-ray irradiation, the expression of p35 was significantly down-regulated, but it was up-regulated in p25. These opposite expressions were also shown in the primary cultured hippocampal neurons with 30 Gy irradiation. The apoptosis induced by X-ray irradiation were significantly prevented by the pretreatment of Cdk5 inhibitor, roscovitine, in both in vivo and in vitro settings.
X-ray irradiation resulted in a hippocampal neuronal apoptosis through up-regulation of p25, the Cdk5 activator. Hyperactivity of Cdk5 was involved in the pathogenesis of X-ray irradiation-induced hippocampal neuronal apoptosis. Blockade of Cdk5 signal pathway effectively protected neurons from the irradiation-induced brain injury.
KeywordsCdk5 p35 p25 Apoptosis Irradiation Hippocampus
Cranial radiation therapy is important in the treatment of primary and metastatic brain tumors. Despite its ability to prolong the survival of patients, the use of radiation therapy is limited by toxicity to the normal brain function. Hippocampal dysfunction is a prominent feature of brain injury resulted from radiation therapy, characterized by a progressive decline in the learning, memory, and spatial information processing abilities [1–3]. However, the mechanisms behind the hippocampus-dependent cognitive dysfunction caused by radiation therapy have not been established.
The most commonly reported cellular mechanisms underlying radiation-mediated injury are via breakup of DNA and consequent disruption of many signal pathways involved in cell cycle, apoptosis and stress response . Hippocampus is particularly vulnerable to ionizing radiation. Radiation-induced learning and memory deficits have been reported, and are associated with an increase in hippocampal apoptosis [5, 6] and a decrease in neurogenesis [6–8]. It is likely that hippocampal vulnerability may result from cellular components involved in both hippocampal apoptosis and neurogenesis. However, the cellular mechanisms underlying the vulnerability of hippocampus remain to be elucidated.
Cdk5 is highly enriched in the hippocampus, and plays a critical role in memory formation, hippocampal apoptosis and adult hippocampal neurogenesis [9, 10]. Therefore, it may be attractive target for radiation-induced hippocampal injury. Cdk5, a proline-directed serine/threonine kinase, plays an important role in the physiological functions such as synaptic plasticity, memory formation [9, 11, 12], and some diseases including Alzheimer’s disease, Parkinson’s disease, and hippocampal sclerosis [9, 13, 14]. The activity of Cdk5 depends on its activator p35, which can be cleaved to p25 by calpain. p25, the truncated form of p35, binds and hyper-activates Cdk5, and the hyper-activation of Cdk5 by p25 plays a prominent role in neuro-degeneration [15, 16]. In addition, the expression of Cdk5 is up-regulated during neuronal death in response to different toxic stimuli, such as oxidative stress, excitotoxic stimulation, and β-amyloid exposure [15, 17–19]. However, the roles of Cdk5 in hippocampal apoptosis and its inhibitor, roscovitine, in protective effects on the memory loss in response to X-ray irradiation have not been explored. In the present study, therefore, we explored the X-ray-induced cell apoptosis and protection of roscovitine from the apoptosis in both in vitro and in vivo hippocampal neurons.
Roscovitine protected hippocampal cells from apoptosis caused by X-ray irradiation
p35 and p25 were linked with activation of Cdk5 after X-ray irradiation
Cdk5 was involved in hippocampal neuronal apoptosis induced by X-ray irradiation
X-ray irradiation results in neuronal apoptosis via DNA damage, which disrupts signal pathways involved in apoptosis . Many stress insults including oxidative stress , excitotoxic stimulation [21, 22], and β-amyloid exposure  have been reported to induce neuronal apoptosis. Neuronal apoptosis also occur in the neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [24, 25]. It has been reported that hyperactivity of Cdk5 is associated with the neuro-degeneration in Alzheimer’s disease and Parkinson’s disease [13, 14, 26], and plays an important role in neuronal apoptosis resulted from those stress insults [20–23]. However, the role of Cdk5 in X-ray induced-apoptosis remains largely unknown. In this study, therefore, we investigated the expression of Cdk5/p25 in X-ray induced apoptosis in hippocampal neurons. Results from the present study showed that the expression of Cdk5/p25 was up-regulated in hippocampal neurons after X-ray irradiation, and inhibition of Cdk5 activity prevented hippocampal neuronal apoptosis induced by X-ray irradiation.
Cdk5 plays an important role in neuronal migration, axon guidance, cytoskeletal protein phosphorylation, and synaptic transmission [11, 12]; activity of Cdk5 is tightly regulated by its neuron-specific activator p35/p39. The breakdown of p35 by calpain into p25, a stable form of p35, increases Cdk5 kinase activity. However, abnormal activation of Cdk5 is toxic to neurons, leading to apoptosis under both physiological and pathological conditions [15, 16]. Hyperactivity of Cdk5 has been reported in neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis [13, 14, 26]. In agreement with Cdk5 hyperactivity leading to neuronal apoptosis, the expression of p25 was elevated by X-ray irradiation, and the pretreatment of Cdk5 inhibitor, roscovitine, significantly prevented the neuronal apoptosis resulted from X-ray irradiation, suggesting that X-ray irradiation resulted in neuronal apoptosis through hyperactivity of Cdk5.
Several studies have shown that inhibition of Cdk5 can protect neurons from apoptosis. Cdk5 inhibitory peptide, which effectively inhibits Cdk5 kinase activity (29), reduces neuronal apoptosis induced by β-amyloid . Cdk5 inhibition by Cdk5 inhibitor butyrolactone and Cdk5 antisense nucleotides also protects neurons from β-amyloid- mediated cell death [15, 28]. In consistent with the idea that inhibition of Cdk5 produces neuroprotective effects, our results showed that pretreatment of roscovitine prevented X-ray irradiation-induced apoptosis in both in vivo and in vitro settings.
It is well known that X-ray irradiation causes cell death via breakup of the DNA . Activation of Cdk5 plays an important role in neuronal death induced by DNA damage . However, it is unclear how Cdk5 is activated after DNA damage. Our study showed that X-ray irradiation resulted in an up-regulated expression of p25 associated with a decrease in p35 expression, suggesting that X-ray irradiation activated Cdk5 through calpain-mediated cleavage of p35 to a more stable p25. Hyperactivity of Cdk5 has been reported to result in neuronal apoptosis . However, the signal pathways leading to the activation of p25 at X-ray irradiation-induced DNA damage need to be elucidated in the future studies.
X-ray irradiation enhanced the levels of p25 in hippocampal neurons in both in vivo rats and in vitro cultured hippocampal neurons, which suggested that hyperactivity of Cdk5 was involved in the pathogenesis of radiation-induced hippocampal neuron injury. Inhibition of Cdk5 activity by the Cdk5 inhibitor, roscovitine, significantly protected hippocampal neuronal cells from death, which suggested that the blockade of Cdk5 signal pathways was an effective strategy to protect neurons from X-ray-induced brain injury during cranial radiation therapy.
The experimental protocols were approved by the Committee for Animal Experiment of the Southern Medical University.
Male Sprague Dawley rats (weighing 200±20 g) were used for X-ray irradiation. One-day Sprague Dawley rats were used for hippocampal culture. All rats were obtained from animal center at Southern Medical University. The rats were fed a standard animal diet.
Intravenous administration of roscovitine
To determine protective effects of roscovitine on hippocampal CA1 neurons in rats, twelve rats were randomly assigned to two groups (n=6 in each group) receiving roscovitine and saline, respectively. Roscovitine was intravenously administrated at dose of 30 mg/kg in a volume of 1mL through a tail vein 30 min before irradiation, and the saline group was intravenously injected in the same volume of saline. Roscovitine was dissolved in dimethyl sulfoxide (Me2SO) by following the previously reported method .
Rats were intraperitoneally administrated with 10% chloral hydrate (3.5 ml/100 g body weight), and affixed in a Plexiglass plate in the prone position. Whole body radiation was delivered by linear accelerator (Varian Medical Systems, Inc. Palo Alto, CA, USA) using 12 MeV electron beam at a dose of 400 cGy/min with a source-skin distance of 100 cm. For the sham-irradiated control groups, a lead shield was used to protect rats. The animals, depending on the radiation used, were assigned to three groups: 10, 20, and 30 Gy radiation (n=6 in each group). The animals receiving roscovitine and saline underwent 30 Gy radiation only.
For the primary cultured hippocampal neurons, X-ray irradiation was performed by 6 MeV electron beam at a dose rate of 400 cGy/min. The in vitro cells were undergone with a single dose of 30 Gy, and the control cells acted as a sham-irradiated under the same conditions.
Hippocampal neuron culture
Hippocampal neurons were prepared from hippocampi of newly born rats as described by Katsube et al. . Briefly, hippocampi were cut into small pieces, and incubated in 0.25% trypsin for 5 min. The hippocampi were then triturated by aspirating about 10 times using a pasterur pipette. The cells were plated in Neurobasal medium on poly-L-lysine coated culture dishes for 72 hours. Cytosine-b-D-arabinofuranoside (5 μM) was added to the culture dishes to inhibit non-neuronal cell proliferation. After 12-day culture, the neurons were identified using phosphorylated neurofilament antibodies. Cells with neuronal purity of more than 90% were used for the experiments.
For Western blot analysis, hippocampal tissue was dissected from the brain. The hippocampal tissue or cultured hippocampal neurons were homogenized on ice in lysis buffer. Proteins were separated by electrophoresis in 10% SDS–PAGE, and transferred onto polyvinylidene fluoride membranes by electroblotting. Membranes were rehydrated with methanol and incubated in buffer (5% powdered milk in PBS) for 30 min. Membranes were incubated with primary antibodies against p35/p25 (C-19, dilution 1:1000, Cell Signaling, USA) or primary antibodies against β-actin (dilution) at 4°C overnight. Blots were developed using horseradish peroxidase-linked secondary antibodies (dilution 1:5000) and a chemiluminescent detection system as recommended by the manufacturer.
Quantification of apoptosis
Rats were intraperitoneally administrated by 10% chloral hydrate (3.5ml/100 g), and were perfused with 4% formaldehyde via the left ventricular. The brains of the animals were dissected, and post-fixed at 4% formaldehyde for 4 hours. The tissues were dehydrated with graded ethanol at the concentration of 60 to 100%, cleared in xylene, filtrated in paraffin wax, and embedded in paraffin wax for 48 hours. Sections (6 μm thick) were obtained using a freezing sliding microtome. After deparaffinization, the sections were stained with Nissl solution (cresyl violet acetate) for 15 minutes, and then dehydrated and mounted on the slides. The morphology of hippocampal neurons in CA1 region was examined, and the number of hippocampal neurons was counted in a 1 mm length of the middle portion of hippocampal CA1 region under bright-filed microscopy.
After irradiation, cultured hippocampal neurons were treated with 1 μg/ml DAPI in methanol, and incubated at 37°C for 15 minutes. The staining solution was washed off with methanol and PBS. The morphology and number of hippocampal neurons were examined under fluorescent microscope. Roscovitine, Cdk5 inhibitor, was added into the cells 15 min before irradiation.
DAPI used in this study contains DNA-specific dye. This dye can pass through cell membranes, apoptosis increases cell membrane permeability and uptake of DAPI, leaving a blue stain. Apoptotic cells show irregular edges around the nucleus, chromosome concentration in the nucleus, heavier coloring, and, with nuclear pyknosis, an increased number of nuclear body fragments. For these reasons, the intensity of the fluorescence can help identify more accurate apoptotic cells when using DAPI images than TdT-Mediated dUTP Nick-End Labeling (TUNEL) staining, as TUNEL technique used in our previously unpublished studies has showed less accurate apoptotic cells.
Analyses were performed using SPSS 13.0. All values were presented as mean and standard deviation. Student t test or analysis of variance (ANOVA) was used to compare the difference. Probability values less than 0.05 were considered statistically significant.
This study was supported by the National Natural Science Foundation of China (No. 30973846), Natural Science Foundation of Guangdong Province (No. S2011010003907), and Guangdong Science and Technology Program (No. 2011B031800244). We thank MWTC for providing medical writing services.
- Hall P, Adami HO, Trichopoulos D, Pedersen NL, Lagiou P, Ekbom A, Ingvar M, Lundell M, Granath F: Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ. 2004, 328: 19-10.1136/bmj.328.7430.19.PubMed CentralView ArticlePubMedGoogle Scholar
- Monje ML, Palmer T: Radiation injury and neurogenesis. Curr Opin Neurol. 2003, 16: 129-134. 10.1097/00019052-200304000-00002.View ArticlePubMedGoogle Scholar
- Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, Paetau A, Kallio M, Pyykkonen J, Jaaskelainen J: Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 2001, 56: 1285-1290. 10.1212/WNL.56.10.1285.View ArticlePubMedGoogle Scholar
- Watters D: Molecular mechanisms of ionizing radiation-induced apoptosis. Immunol Cell Biol. 1999, 77: 263-271. 10.1046/j.1440-1711.1999.00824.x.View ArticlePubMedGoogle Scholar
- Peissner W, Kocher M, Treuer H, Gillardon F: Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res Mol Brain Res. 1999, 71: 61-68. 10.1016/S0169-328X(99)00170-9.View ArticlePubMedGoogle Scholar
- Tada E, Parent JM, Lowenstein DH, Fike JR: X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience. 2000, 99: 33-41. 10.1016/S0306-4522(00)00151-2.View ArticlePubMedGoogle Scholar
- Monje ML, Mizumatsu S, Fike JR, Palmer TD: Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002, 8: 955-962. 10.1038/nm749.View ArticlePubMedGoogle Scholar
- Parent JM, Tada E, Fike JR, Lowenstein DH: Inhibition of dentate granule cell neurogenesis with brain irradiation does not prevent seizure-induced mossy fiber synaptic reorganization in the rat. J Neurosci. 1999, 19: 4508-4519.PubMedGoogle Scholar
- Giese KP: Novel insights into the beneficial and detrimental actions of cdk5. Mol Interv. 2007, 7: 246-248. 10.1124/mi.7.5.5.View ArticlePubMedGoogle Scholar
- Lagace DC, Benavides DR, Kansy JW, Mapelli M, Greengard P, Bibb JA, Eisch AJ: Cdk5 is essential for adult hippocampal neurogenesis. Proc Natl Acad Sci USA. 2008, 105: 18567-18571. 10.1073/pnas.0810137105.PubMed CentralView ArticlePubMedGoogle Scholar
- Gupta A, Tsai LH: Cyclin-dependent kinase 5 and neuronal migration in the neocortex. Neurosignals. 2003, 12: 173-179. 10.1159/000074618.View ArticlePubMedGoogle Scholar
- Smith DS, Tsai LH: Cdk5 behind the wheel: a role in trafficking and transport?. Trends Cell Biol. 2002, 12: 28-36. 10.1016/S0962-8924(01)02181-X.View ArticlePubMedGoogle Scholar
- Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH: Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron. 2005, 48: 825-838. 10.1016/j.neuron.2005.10.033.View ArticlePubMedGoogle Scholar
- Qu D, Rashidian J, Mount MP, Aleyasin H, Parsanejad M, Lira A, Haque E, Zhang Y, Callaghan S, Daigle M, Rousseaux MW, Slack RS, Albert PR, Vincent I, Woulfe JM, Park DS: Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron. 2007, 55: 37-52. 10.1016/j.neuron.2007.05.033.View ArticlePubMedGoogle Scholar
- Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH: Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 2000, 405: 360-364. 10.1038/35012636.View ArticlePubMedGoogle Scholar
- Shelton SB, Johnson GV: Cyclin-dependent kinase-5 in neurodegeneration. J Neurochem. 2004, 88: 1313-1326. 10.1111/j.1471-4159.2003.02328.x.View ArticlePubMedGoogle Scholar
- Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T: Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons. Neurosci Lett. 2004, 368: 181-185. 10.1016/j.neulet.2004.07.007.View ArticlePubMedGoogle Scholar
- Lee JH, Kim HS, Lee SJ, Kim KT: Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci. 2007, 120: 2259-2271. 10.1242/jcs.03468.View ArticlePubMedGoogle Scholar
- Utreras E, Maccioni R, Gonzalez-Billault C: Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells. Neuroscience. 2009, 161: 978-987. 10.1016/j.neuroscience.2009.04.002.View ArticlePubMedGoogle Scholar
- Wei T, Chen C, Hou J, Xin W, Mori A: Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta. 2000, 1498: 72-79. 10.1016/S0167-4889(00)00078-1.View ArticlePubMedGoogle Scholar
- Gillardon F, Wickert H, Zimmermann M: Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci Lett. 1995, 192: 85-88. 10.1016/0304-3940(95)11619-8.View ArticlePubMedGoogle Scholar
- Pollard H, Charriaut-Marlangue C, Cantagrel S, Represa A, Robain O, Moreau J, Ben-Ari Y: Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 1994, 63: 7-18. 10.1016/0306-4522(94)90003-5.View ArticlePubMedGoogle Scholar
- Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW: Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA. 1993, 90: 7951-7955. 10.1073/pnas.90.17.7951.PubMed CentralView ArticlePubMedGoogle Scholar
- Shimohama S: Apoptosis in Alzheimer's disease–an update. Apoptosis. 2000, 5: 9-16. 10.1023/A:1009625323388.View ArticlePubMedGoogle Scholar
- Tatton WG, Chalmers-Redman R, Brown D, Tatton N: Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol. 2003, 3 (53): 61-70.View ArticleGoogle Scholar
- Giese KP, Ris L, Plattner F: Is there a role of the cyclin-dependent kinase 5 activator p25 in Alzheimer's disease?. Neuroreport. 2005, 16: 1725-1730. 10.1097/01.wnr.0000185019.67434.d2.View ArticlePubMedGoogle Scholar
- Zheng YL, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, Albers W, Grant P, Pant HC: A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005, 24: 209-220. 10.1038/sj.emboj.7600441.PubMed CentralView ArticlePubMedGoogle Scholar
- Amin ND, Albers W, Pant HC: Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res. 2002, 67: 354-362. 10.1002/jnr.10116.View ArticlePubMedGoogle Scholar
- Lee JH, Kim KT: Regulation of cyclin-dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage-induced neuronal death. J Cell Physiol. 2007, 210: 784-797. 10.1002/jcp.20899.View ArticlePubMedGoogle Scholar
- Wang C-H, Chou W-Y, Hung K-S, Jawan B, Lu C-N, Liu J-K, Hung Y-P, Lee T-H: Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats. Acta Pharmacologica cologica Sinica. 2005, 26 (1): 46-50. 10.1111/j.1745-7254.2005.00007.x.View ArticleGoogle Scholar
- Katsube N, Sunaga K, Aishita H, Chuang DM, Ishitani R: ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons. J Pharmacol Exp Ther. 1999, 288: 6-13.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.